News Releases

September 14, 2020
Synlogic Appoints David Hava, Ph.D., as Chief Scientific Officer
CAMBRIDGE, Mass. , Sept. 14, 2020 /PRNewswire/ --  Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced the appointment of David Hava , Ph.D. as Chief Scientific Officer. Dr....
September 8, 2020
Synlogic to Present at Upcoming Virtual Banking Conferences
CAMBRIDGE, Mass. , Sept. 8, 2020 /PRNewswire/ --  Synlogic, Inc. ( Nasdaq: SYBX ), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced that Aoife Brennan , M.B. Ch.B., Synlogic's president and chief executive officer, and other members of...
August 6, 2020
Synlogic Reports Second Quarter 2020 Financial Results and Provides Business Update
- Synlogic ends 2Q2020 with $109.1 million in cash, cash equivalents and investments supporting projected runway into 2022 - Company continues to advance multiple clinical stage Synthetic Biotic medicines - Management to host conference call and webcast at 8:00 am ET today - CAMBRIDGE,...
July 31, 2020
Synlogic to Present at Upcoming Virtual Banking Conferences
CAMBRIDGE, Mass. , July 31, 2020 /PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced that Aoife Brennan , M.B. Ch.B., Synlogic's president and chief executive officer, and other members of...
July 30, 2020
Synlogic Announces Promotion of Antoine 'Tony' Awad to Chief Operating Officer and Additions to Leadership Team
CAMBRIDGE, Mass. , July 30, 2020 /PRNewswire/ --  Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced the promotion of Antoine 'Tony' Awad to the position of Chief Operating Officer....
July 28, 2020
Synlogic Announces Second Quarter 2020 Conference Call & Webcast
CAMBRIDGE, Mass. , July 28, 2020 /PRNewswire/ --  Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced the Company will release its second quarter 2020 financial results before the market opens on Thursday,...
June 1, 2020
Publication in Nature Communications Highlights the Preclinical Development of SYNB1891 and its Potential as a Dual Innate Immune Activator to Stimulate an Immune Response in Difficult to Treat Tumors
- SYNB1891 is currently being evaluated in a Phase 1 clinical trial in patients with advanced solid tumors or lymphoma - CAMBRIDGE, Mass. , June 1, 2020 /PRNewswire/ --  Synlogic, Inc., (Nasdaq: SYBX) a clinical stage company applying synthetic biology to beneficial microbes to develop novel,...
May 27, 2020
Synlogic Hosts First Virtual R&D Event
Live Webcast Scheduled to Begin at 12.30 pm ET Today CAMBRIDGE, Mass. , May 27, 2020 /PRNewswire/ --  Synlogic (Nasdaq: SYBX) today will host its first Virtual R&D Event which will include presentations from members of the Synlogic executive team providing an in-depth review of Synlogic's Synthetic...
May 21, 2020
Synlogic to Host Virtual R&D Event
CAMBRIDGE, Mass. , May 21, 2020 /PRNewswire/ --  Synlogic (Nasdaq: SYBX) announced today that the company will host a Virtual R&D Event at 12:30 pm ET on Wednesday, May 27th, 2020 . The event will provide an in-depth review of Synlogic's Synthetic Biotic platform and programs for the treatment of...
May 21, 2020
Synlogic Announces Termination of AbbVie Collaboration Agreement
CAMBRIDGE, Mass. , May 21, 2020 /PRNewswire/ --  Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company applying synthetic biology to beneficial microbes to develop novel, living medicines, today announced the termination of its collaboration with AbbVie, a global, research-based biopharmaceutical...
May 8, 2020
Synlogic Reports First Quarter 2020 Financial Results and Provides Business Update
-Cash and investments of $114 million provide runway into 2022 - -Company will host virtual R&D event highlighting progress in its Synthetic Biotic platform and programs on Wednesday, May 27, 2020 - - Company will host a conference call at 8:00 am ET today - CAMBRIDGE, Mass....
May 4, 2020
Synlogic Announces First Quarter 2020 Conference Call and Webcast
CAMBRIDGE, Mass. , May 4, 2020 /PRNewswire/ --  Synlogic, Inc.  (Nasdaq: SYBX), a clinical stage company applying synthetic biology to beneficial microbes to develop novel, living medicines, announced today that the Company will release its first quarter 2020 financial results before the market...
Displaying 1 - 12 of 115